Wuhan Hvsen Biotechnology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	310.2	326.14	293.61	424.04	1,068
Trading Asset Securities	160.33	200.97	304.26	361.68	30.22
Cash & Short-Term Investments	470.53	527.11	597.87	785.72	1,098
Cash Growth	-10.73%	-11.83%	-23.91%	-28.47%	39.57%
Accounts Receivable	456.32	446.27	369.11	354.41	249.4
Other Receivables	17.75	19.8	7.42	1.7	10.07
Receivables	474.07	466.07	376.53	356.11	259.46
Inventory	267.89	248.16	228.67	199.01	231.55
Other Current Assets	94.44	71.24	62.91	10.64	9.42
Total Current Assets	1,307	1,313	1,266	1,351	1,599
Property, Plant & Equipment	1,551	1,543	1,566	1,498	1,007
Goodwill	0.52	-	-	-	-
Other Intangible Assets	110.57	114.44	104.17	106.87	110.06
Long-Term Deferred Tax Assets	23.45	27.17	21.65	12.91	10.46
Long-Term Deferred Charges	0.95	1.9	2.72	0.37	-
Other Long-Term Assets	14.9	15.25	14.78	19.4	15.46
Total Assets	3,009	3,015	2,975	2,989	2,742
Accounts Payable	391.2	507.3	472.47	489.7	311.33
Accrued Expenses	30.54	22.88	26.72	33.67	27.59
Short-Term Debt	173.85	316.78	240.32	220.08	100
Current Portion of Long-Term Debt	30.03	16.32	0.27	-	-
Current Portion of Leases	-	-	-	-	6.42
Current Income Taxes Payable	15.63	0.04	3.17	6.25	2.56
Current Unearned Revenue	19.51	13.47	10.27	15.62	13.87
Other Current Liabilities	79.57	46.52	27.86	39.6	41.5
Total Current Liabilities	740.33	923.32	781.08	804.93	503.27
Long-Term Debt	24.72	555.45	601.66	570.36	574.56
Long-Term Unearned Revenue	52.57	58.34	62.34	48.89	42.08
Long-Term Deferred Tax Liabilities	2.8	11.37	20.26	21.82	-
Other Long-Term Liabilities	1.75	1	0.85	1.69	2.9
Total Liabilities	822.17	1,549	1,466	1,448	1,123
Common Stock	202.33	165.77	165.89	166.05	166.25
Additional Paid-In Capital	1,451	880.63	874.01	877.08	881.6
Retained Earnings	541.76	330.21	394.92	427.11	429.31
Treasury Stock	-18.09	-17.57	-52.42	-55.73	-9.52
Comprehensive Income & Other	-3.78	98.54	126.89	126.92	151.21
Total Common Equity	2,174	1,458	1,509	1,541	1,619
Minority Interest	12.78	7.63	-	-	-
Shareholders' Equity	2,186	1,465	1,509	1,541	1,619
Total Liabilities & Equity	3,009	3,015	2,975	2,989	2,742
Total Debt	228.6	888.56	842.24	790.45	680.98
Net Cash (Debt)	241.93	-361.45	-244.38	-4.72	417.47
Net Cash Growth	-	-	-	-	-41.03%
Net Cash Per Share	1.23	-2.18	-1.47	-0.03	2.52
Filing Date Shares Outstanding	202.31	165.01	163.5	163.67	166.25
Total Common Shares Outstanding	202.31	165.01	163.5	163.67	166.25
Working Capital	566.6	389.27	484.9	546.55	1,096
Book Value Per Share	10.74	8.83	9.23	9.42	9.74
Tangible Book Value	2,063	1,343	1,405	1,435	1,509
Tangible Book Value Per Share	10.19	8.14	8.59	8.77	9.08
Buildings	-	670.73	647.31	521.54	385.01
Machinery	-	1,231	1,135	798.62	204.86
Construction In Progress	-	18.15	53.13	332.51	473.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.